Monika Karki
Internal Medicine · Fort Lauderdale, FLNPI 1750842795
Payments from drug & device makers
What this record shows
This record is dominated by grants: $30,000 of the $35,899 with a category attached, or 83.6%. Abbott accounts for 84.9% of it on its own, with 24 other manufacturers making up the rest. 2025 is the largest year on record at $34,152, more than ten times the $45 reported in 2023. Among internal medicine clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 102 payments — averaging $351.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$30K
- Boston Scientific$2K
- Stryker$878
- Abiomed$602
- Cardiva Medical, Inc.$337
- Inari Medical, Inc.$289
- plus $2K from 19 others
What the payments were for
- Grants$30,00084%
- Travel & lodging$1,3764%
- Food & beverage$4,26712%
- Education$2561%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 8 | $30,466 |
| Boston Scientific | 16 | $1,532 |
| Stryker | 6 | $878 |
| Abiomed | 16 | $602 |
| Cardiva Medical, Inc. | 14 | $337 |
| Inari Medical, Inc. | 2 | $289 |
| Heartflow, Inc. | 5 | $202 |
| Edwards Lifesciences | 2 | $172 |
| Boehringer Ingelheim | 2 | $152 |
| Acist Medical Systems, Inc. | 1 | $146 |
| Teleflex LLC | 5 | $144 |
| Penumbra, Inc. | 1 | $141 |
| Shockwave Medical, Inc | 1 | $141 |
| Chiesi USA, Inc. | 3 | $119 |
| Angiodynamics, Inc. | 1 | $118 |
| Bard Peripheral Vascular, Inc. | 4 | $106 |
| Novartis | 4 | $92 |
| Pfizer | 3 | $63 |
| Medtronic | 2 | $45 |
| Biosense Webster, Inc. | 1 | $33 |
| Atricure, Inc. | 1 | $28 |
| Impulse Dynamics (USA) Inc. | 1 | $27 |
| Amgen | 1 | $26 |
| W. L. Gore & Associates, Inc. | 1 | $25 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XIENCE V$30,000
- GENERAL VASCULAR ACCESS$641
- FLOWTRIEVER CATHETER, S$603
- CT THROMBECTOMY SYSTEM KIT$603
- CLOTTRIEVER BOLD CATHETER$458
- ENSITE$256
- General Vascular Access IC$160
- CVI SYSTEMS$146
- Indigo System$141
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$141
- ACCOLADE SR$126
- JARDIANCE$125
- Impella$124
- SAPIEN 3 Ultra RESILIA$124
- AngioVac$118
- FFRct$114
How this compares
$35,899 in reported general payments places this provider in the 95th percentile of 8,530 internal medicine providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 19 | $31,403 |
| EliquisApixaban | 19 | $22,102 |
| BrilintaTicagrelor | 23 | $15,891 |
| Atorvastatin Calcium | 85 | $751 |
| Ezetimibe | 31 | $594 |
| Metoprolol Succinate | 50 | $538 |
| Rosuvastatin Calcium | 27 | $431 |
| Valsartan | 18 | $405 |
| ClopidogrelClopidogrel Bisulfate | 45 | $339 |
| Famotidine | 29 | $338 |
| Lisinopril | 29 | $312 |
| Amlodipine Besylate | 44 | $252 |
| Metoprolol Tartrate | 22 | $215 |
| Carvedilol | 33 | $182 |
| Hydralazine Hcl | 12 | $175 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisEntresto | $92 | $31,40319 claims |
| PfizerEliquis | $63 | $22,10219 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,530 internal medicine providers in Florida.
Other internal medicine in Fort Lauderdale
- Keith RubinFort Lauderdale$2M
- Michael SensionFort Lauderdale$1M
- Sheetal SharmaFort Lauderdale$184K
- Evan WuFort Lauderdale$114K
- Haytham ElgammalMiami$2.2M
- Quang NguyenOcala$434K
- Luis Correa LunaSanford$412K
- Michael OleksykFort Myers$365K
- Andrew KuykendallTampa$322K
- Howard FederoffCoconut Grove$302K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.